Characterization of the MRC OX40 antigen of activated CD4 positive T lymphocytes--a molecule related to nerve growth factor receptor
about
Nerve growth factor binding domain of the nerve growth factor receptorIdentification of a human OX-40 ligand, a costimulator of CD4+ T cells with homology to tumor necrosis factor4-1BB and Ox40 are members of a tumor necrosis factor (TNF)-nerve growth factor receptor subfamily that bind TNF receptor-associated factors and activate nuclear factor kappaBMolecular characterization of murine and human OX40/OX40 ligand systems: identification of a human OX40 ligand as the HTLV-1-regulated protein gp34Cytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptorTRAF5, a novel tumor necrosis factor receptor-associated factor family protein, mediates CD40 signalingOX-22high CD4+ T cells induce wasting disease with multiple organ pathology: prevention by the OX-22low subsetScience gone translational: the OX40 agonist storyStructures of CD200/CD200 Receptor Family and Implications for Topology, Regulation, and EvolutionCloning and expression of cDNAs for two distinct murine tumor necrosis factor receptors demonstrate one receptor is species specific.Pathogenic roles of CD14, galectin-3, and OX40 during experimental cerebral malaria in mice.Cloning of human tumor necrosis factor (TNF) receptor cDNA and expression of recombinant soluble TNF-binding protein.Control of immunity by the TNFR-related molecule OX40 (CD134)The upregulated expression of OX40/OX40L and their promotion of T cells proliferation in the murine model of asthmaAntibody-based immunotherapy for malignant glioma.Tissue specific deletion of inhibitor of kappa B kinase 2 with OX40-Cre reveals the unanticipated expression from the OX40 locus in skin epidermis.OX40 is a potent immune-stimulating target in late-stage cancer patients.Targeting CD8+ T-cell tolerance for cancer immunotherapy.CD28 expression is required after T cell priming for helper T cell responses and protective immunity to infection.Immune modulation for cancer therapy.The significance of OX40 and OX40L to T-cell biology and immune disease.Mapping the domains of CD134 as a functional receptor for feline immunodeficiency virus.Expression of lymphocyte-endothelial receptor-ligand pairs, alpha4beta7/MAdCAM-1 and OX40/OX40 ligand in the colon and jejunum of patients with inflammatory bowel diseaseMouse stem cell antigen Sca-2 is a member of the Ly-6 family of cell surface proteinsDevelopment and characterization of recombinant human Fc:OX40L fusion protein linked via a coiled-coil trimerization domainOX40 ligand expressed by DCs costimulates NKT and CD4+ Th cell antitumor immunity in mice.Bone marrow transplantation and approaches to avoid graft-versus-host disease (GVHD).The human OX40/gp34 system directly mediates adhesion of activated T cells to vascular endothelial cells.OX40 (CD134) controls memory T helper 2 cells that drive lung inflammation.Impairment of antigen-presenting cell function in mice lacking expression of OX40 ligand.Identification of Single Nucleotide Polymorphism Marker and Association Analysis of Marbling Score in Fas Gene of Hanwoo.Chemokine receptors and co-stimulatory molecules: unravelling feline immunodeficiency virus infection.T-cell activation in the intestinal mucosa.Enhancing the safety of antibody-based immunomodulatory cancer therapy without compromising therapeutic benefit: Can we have our cake and eat it too?T-cell activation molecule 4-1BB binds to extracellular matrix proteins.Thymic OX40 expression discriminates cells undergoing strong responses to selection ligands.The role of OX40-mediated co-stimulation in T-cell activation and survival.Signaling through OX40 enhances antitumor immunity.The TNFRs OX40, 4-1BB, and CD40 as targets for cancer immunotherapy.Betting on improved cancer immunotherapy by doubling down on CD134 and CD137 co-stimulation.
P2860
Q24310194-58BC3C80-A430-4507-9169-F70D5E0B2551Q24319938-57205E3E-50D7-4281-890F-006C39172873Q24533857-22496787-E107-42DE-9121-FC404D0A1660Q24568305-D8329C58-256A-45D0-9CD6-186673B4CDA5Q24597543-52BEDB7B-687C-40C4-93A8-AC75E8F51E3AQ24634187-BD3F563C-E0AE-4F69-99C6-B1E099B4666DQ24682576-0AA611E6-6ED9-4803-BE5A-0BE8B1419F60Q27022436-2667ACF3-C249-4D29-8AA0-CF4D7D8D6587Q27677459-0995496A-140F-4271-B228-301D5EC090C1Q33336314-422A5385-C38A-4DEB-A700-F7169A90ECC6Q33497309-6E7B768C-F081-4555-9305-A0D5D3DEDF98Q33810622-ABAE6367-9416-43F1-A498-02E9409E09B5Q33899607-D37879AF-46CE-46D2-9870-AA407E41AAA8Q33995167-8888E09E-6BB1-4335-9DE3-C8D9B6B9ACF5Q34120472-6563DF3D-6427-414C-96FB-485B47E09A4BQ34171710-EF53300E-79A1-45AE-8F4F-49EE2193508FQ34381674-426979A8-FB05-477E-8516-B249A61360A4Q34432692-C893D0D9-CDC6-4F09-9B63-735CED0152D8Q34561705-0FD0261E-A4E1-4827-BB29-135760A03C52Q34686944-C4675EE3-4EE8-404F-BE14-AE40A9D1BFCAQ34979946-DB39814D-FB06-4C0B-8200-36EA21E819F3Q35023787-5566EA49-71B5-4D8B-AE86-1EA1CF47FC73Q35357996-9A19C70F-14E8-4570-B002-0CEE18E3582AQ35429605-E5CD9475-F3EE-4AA8-AE58-8FF14C7B852AQ35946627-05828FB7-135D-404B-9CEA-F91DBDD29CA1Q36099421-846B0DB8-998B-4FFB-8AB4-708B31F08882Q36251308-1AEA990C-5D0C-40E4-8147-A06919A8C23FQ36366597-75442785-B8D2-40FE-B24B-A27042E3241BQ36371325-81D218BB-4EA9-4DFB-AFFE-7280F9620A11Q36375697-72D98FBB-B98C-4AAF-BE73-47D3339FDC5EQ36423282-99E6E7DC-EF7B-4DE3-96DF-1D657C5FED18Q36699711-1DC45642-14E5-4886-AA2F-58522CE906DDQ36732698-E15A2BE1-E623-4061-BF82-AFA850604092Q37114367-158170C3-A76E-40AF-82EE-14EB631757BAQ37277146-A0D4BBA3-62B9-4E11-9C3A-76437EFD8A04Q37330125-EEB22ACC-652D-461C-BE9C-421D739F3700Q37524064-867ED596-2FB1-47EC-8901-F98063B9780DQ37809163-2A928A43-1392-40C4-9DD8-99DE06527D94Q38081999-881A5B48-67E7-4530-BA4F-436F3BD832FAQ38088635-805FA84D-9282-41CE-823D-0222CD7C2FBB
P2860
Characterization of the MRC OX40 antigen of activated CD4 positive T lymphocytes--a molecule related to nerve growth factor receptor
description
1990 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1990 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 1990
@ast
im April 1990 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 1990/04/01)
@sk
vědecký článek publikovaný v roce 1990
@cs
wetenschappelijk artikel (gepubliceerd op 1990/04/01)
@nl
наукова стаття, опублікована у квітні 1990
@uk
مقالة علمية (نشرت في أبريل 1990)
@ar
name
Characterization of the MRC OX ...... o nerve growth factor receptor
@ast
Characterization of the MRC OX ...... o nerve growth factor receptor
@en
Characterization of the MRC OX ...... o nerve growth factor receptor
@nl
type
label
Characterization of the MRC OX ...... o nerve growth factor receptor
@ast
Characterization of the MRC OX ...... o nerve growth factor receptor
@en
Characterization of the MRC OX ...... o nerve growth factor receptor
@nl
prefLabel
Characterization of the MRC OX ...... o nerve growth factor receptor
@ast
Characterization of the MRC OX ...... o nerve growth factor receptor
@en
Characterization of the MRC OX ...... o nerve growth factor receptor
@nl
P2093
P2860
P3181
P1433
P1476
Characterization of the MRC OX ...... o nerve growth factor receptor
@en
P2093
A. N. Barclay
S. Mallett
P2860
P304
P3181
P407
P577
1990-04-01T00:00:00Z